What is the prevalence of STXBP1?

STXBP1-related disorders are considered ultra-rare, with an estimated prevalence ranging from 1 in 30,000 to 1 in 90,000 individuals. While exact global numbers are difficult to confirm due to historical underdiagnosis, STXBP1 is increasingly identified as a significant cause of early-onset developmental and epileptic encephalopathy.

Is STXBP1 considered a rare or common condition?

STXBP1 is classified as an ultra-rare genetic disorder. Because it is caused by pathogenic variants in the STXBP1 gene, it is frequently underdiagnosed in regions with limited access to genomic sequencing. As diagnostic capabilities improve, the number of confirmed cases is rising, though it remains a rare diagnosis compared to more common neurodevelopmental conditions.

What is the typical age of onset and gender distribution?

STXBP1-related disorders typically present in the neonatal period or early infancy, usually within the first few months of life. Most patients experience symptoms of developmental delay and seizures very early. Current clinical data indicates that STXBP1 affects males and females with equal frequency, showing no significant bias toward either gender or specific ethnic backgrounds.

Why is accurate prevalence data challenging to capture?

Determining the true prevalence of STXBP1 is complicated by several factors, including:

• Diagnostic overshadowing: Many patients were previously labeled with generic "epileptic encephalopathy" or "cerebral palsy" before genetic testing became standard.


• Variable presentation: The spectrum of STXBP1 is broad, ranging from severe infantile epilepsy to milder intellectual disabilities, which can delay or prevent diagnosis.


• Access to testing: Wide variability in the availability of whole-exome or whole-genome sequencing globally impacts case detection rates.

How does the DiseaseMaps community compare?

While formal epidemiological studies provide a baseline, real-world data from patient-led organizations is vital. Currently, 271 people with STXBP1 have joined the DiseaseMaps.org community, offering a unique, patient-centered perspective on the lived experience of this condition that complements clinical literature.

Next steps

• Consult with a clinical geneticist to discuss genetic testing options for STXBP1.


• Join the DiseaseMaps.org community to connect with other families and share experiences.


• Review resources from the STXBP1 Foundation for the latest information on clinical research and support.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: STXBP1-related encephalopathy (ORPHA:391439).


• NIH Genetic and Rare Diseases Information Center (GARD): STXBP1 disorder.


• OMIM: STXBP1, SYNTAXIN-BINDING PROTEIN 1 (Entry 602926).


• STXBP1 Foundation: Research and clinical resources.